Metabolites of MDMA Induce Oxidative Stress and Contractile Dysfunction in Adult Rat Left Ventricular Myocytes
- 31 March 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cardiovascular Toxicology
- Vol. 9 (1), 30-38
- https://doi.org/10.1007/s12012-009-9034-6
Abstract
Repeated administration of 3,4-methylenedioxymethamphetamine (MDMA) (ecstasy) produces eccentric left ventricular (LV) dilation and diastolic dysfunction. While the mechanism(s) underlying this toxicity are unknown, oxidative stress plays an important role. MDMA is metabolized into redox cycling metabolites that produce superoxide. In this study, we demonstrated that metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes. Metabolites of MDMA used in this study included alpha-methyl dopamine, N-methyl alpha-methyl dopamine and 2,5-bis(glutathion-S-yl)-alpha-MeDA. Dihydroethidium was used to detect drug-induced increases in reactive oxygen species (ROS) production in ventricular myocytes. Contractile function and changes in intracellular calcium transients were measured in paced (1 Hz), Fura-2 AM loaded, myocytes using the IonOptix system. Production of ROS in ventricular myocytes treated with MDMA was not different from control. In contrast, all three metabolites of MDMA exhibited time- and concentration-dependent increases in ROS that were prevented by N-acetyl-cysteine (NAC). The metabolites of MDMA, but not MDMA alone, significantly decreased contractility and impaired relaxation in myocytes stimulated at 1 Hz. These effects were prevented by NAC. Together, these data suggest that MDMA-induced oxidative stress in the left ventricle can be due, at least in part, to the metabolism of MDMA to redox active metabolites.Keywords
This publication has 46 references indexed in Scilit:
- Ecstasy produces left ventricular dysfunction and oxidative stress in ratsCardiovascular Research, 2008
- Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine (‘Ecstasy’) cytotoxicityPharmacogenetics and Genomics, 2006
- Redox regulation of cardiac calcium channels and transportersCardiovascular Research, 2006
- The toxicity of N-methyl-α-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteineToxicology, 2004
- Enhancing effects of intracellular ascorbic acid on peroxynitrite-induced U937 cell death are mediated by mitochondrial events resulting in enhanced sensitivity to peroxynitrite-dependent inhibition of complex III and formation of hydrogen peroxideBiochemical Journal, 2004
- Atrial Fibrillation in an Adolescent—The Agony of EcstasyPediatric Emergency Care, 2003
- Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular usersHuman Psychopharmacology: Clinical and Experimental, 2003
- Ecstasy induced acute myocardial infarctionHeart, 2001
- Role of Quinones in ToxicologyChemical Research in Toxicology, 2000
- Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotoninJournal of Neural Transmission, 1996